Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Blood|June 10, 2004
Gemtuzumab ozogamicin (Mylotarg) as a single agent for molecularly relapsed acute promyelocytic leukemiaFrancesco Lo-Coco, Giuseppe Cimino, Massimo Breccia, et al.
Annals of Hematology|May 12, 2011
Results of a lymphoblastic leukemia-like chemotherapy program with risk-adapted mediastinal irradiation and stem cell transplantation for adult patients with lymphoblastic lymphomaSergio Cortelazzo, Tamara Intermesoli, Elena Oldani, et al.
American Journal of Hematology|November 16, 2012
Cytarabine and clofarabine after high-dose cytarabine in relapsed or refractory AML patientsBarbara Scappini, Giacomo Gianfaldoni, Francesco Caracciolo, et al.
Haematologica|July 4, 2007
Repeated infusions of donor-derived cytokine-induced killer cells in patients relapsing after allogeneic stem cell transplantation: a phase I studyMartino Introna, Gianmaria Borleri, Elena Conti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 8, 2010
Chemotherapy-phased imatinib pulses improve long-term outcome of adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: Northern Italy Leukemia Group protocol 09/00Renato Bassan, Giuseppe Rossi, Enrico M Pogliani, et al.
The Journal of Antimicrobial Chemotherapy|July 7, 2011
A randomized comparison of caspofungin versus antifungal prophylaxis according to investigator policy in acute leukaemia patients undergoing induction chemotherapy (PROFIL-C study)Chiara Cattaneo, Simona Monte, Alessandra Algarotti, et al.
Blood|August 29, 2012
Final results of a multicenter trial addressing role of CSF flow cytometric analysis in NHL patients at high risk for CNS disseminationGiulia Benevolo, Alessandra Stacchini, Michele Spina, et al.
The New England Journal of Medicine|July 22, 2011
ABVD versus BEACOPP for Hodgkin's lymphoma when high-dose salvage is plannedSimonetta Viviani, Pier Luigi Zinzani, Alessandro Rambaldi, et al.
American Journal of Hematology|January 7, 2010
Leukocytosis is a risk factor for recurrent arterial thrombosis in young patients with polycythemia vera and essential thrombocythemiaValerio De Stefano, Tommaso Za, Elena Rossi, et al.
Leukemia & Lymphoma|February 23, 2011
High response rate and improvement of long-term survival with combined treatment modalities in patients with poor-risk primary thyroid diffuse large B-cell lymphoma: an International Extranodal Lymphoma Study Group and Intergruppo Italiano Linfomi studyMichael Mian, Gianluca Gaidano, Annarita Conconi, et al.
Pageof 3